NASDAQ:CBPO

China Biologic Now Included in the NASDAQ Global Select Market

TAI'AN, China, Jan. 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that NASDAQ has notified it that the Company has m...

2011-01-04 20:30 1810

China Biologic Appoints KPMG as its Independent Registered Public Accounting Firm

TAI'AN, China, Dec. 23, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it has dismissed Frazer Frost, LLP (Frazer Frost") as the Compa...

2010-12-23 21:00 1087

China Biologic Starts Plasma Collection at Yishui Station

TAI'AN, China, Dec. 7, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taiban...

2010-12-07 20:00 3069

China Biologic Special Committee Completes Investigation

TAI'AN, China, Dec. 6, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shando...

2010-12-06 20:00 1718

China Biologic Products Appoints President

TAI'AN, China, Dec. 6, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shando...

2010-12-06 21:00 1502

China Biologic Products Announces Record Third Quarter 2010 Results

- Q3 revenue grew 33.2% to $36.0 million - Non-GAAP adjusted net income grew 48.7% to $10.5 million TAI'AN, China, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical compani...

2010-11-16 20:00 2047

China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference

TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management will present at the upcoming Brean Murray, Carret & Co. 2010 C...

2010-11-15 22:00 1357

China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results

TAI'AN, Shandong, China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 9:00 a.m. EST on Tuesday, November...

2010-11-09 22:14 2295

China Biologic Products Announces Record Second Quarter 2010 Results

-- Q2 revenue grew 23.3% to $40.9 million -- Non-GAAP adjusted net income grew 31.2% to $10.9 million TAI'AN, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical comp...

2010-08-16 18:00 1528

China Biologic Products Schedules Conference Call to Discuss Second Quarter 2010 Results

TAI'AN, China, Aug. 13 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) (the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 8:00 a.m. Eastern Daylight Time on Monday, August 16, 2010, to discuss its s...

2010-08-13 05:21 1690

China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference

TAI'AN, China, July 29 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, S...

2010-07-29 20:30 1190

China Biologic Products to Present at Jeffries 2010 Global Life Sciences Conference

TAI'AN, China, June 8 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will present at the Jeffries 2010 Global Life Sciences Conference, which is b...

2010-06-08 21:33 1663

China Biologic Products Announces First Quarter 2010 Results

- Q1 revenue grew 28.1% to $27.1 million - Non-GAAP adjusted net income grew 60.6% to $7.5 million TAI'AN, China, May 17 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the...

2010-05-17 18:00 1064

China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results

TAI'AN, China, May 14 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 8:00 a.m. EDT on Monday, May 17, 2010, to discuss the fi...

2010-05-14 02:45 1097

China Biologic Products to Build Two New Plasma Stations in Shandong Province

TAI'AN, China, May 12 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong Ta...

2010-05-12 20:00 1088

China Biologic Products to Receive Government Benefits to Continue R&D Innovation

TAI'AN, China, April 27 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong ...

2010-04-27 20:00 1605

China Biologic Products Announces Record Fourth Quarter and Full Year 2009 Results

- Full-year revenue grew 154.5% to $119.0 million - Non-GAAP adjusted net income rose 135.0% to $31.3 million, or $1.38 per diluted share TAI'AN, Shandong, China, March 24 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one o...

2010-03-24 10:20 2098

China Biologic Products Schedules Conference Call to Discuss Fourth Quarter and Full Year 2009 Results

TAI'AN, China, March 22 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 9:00 a.m. EDT on Wednesday, March 24, 2010, to discuss...

2010-03-22 20:00 1566

China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference

TAI'AN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will present at the Rodman & Renshaw Annual C...

2010-03-03 21:00 1751

China Biologic Products Retains O'Melveny & Myers LLP to Advise on Special Investigation

TAI'AN, China, March 1 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the special committee of independent directors appointed by the Company's board of Direct...

2010-03-01 21:00 1277

Week's Top Stories